Nanjaian Mahadevan
- Molecular Biology
- Pharmacology top 2%
- Plant Science
- Cardiology and Cardiovascular Medicine
- Endocrinology, Diabetes and Metabolism top 10%
- Co-authors
- Pitchai BalakumarGaurav TanejaS. RamanathanSanjeev KalraAbdullatif Bin MuhsinahAbdulrhman AlsayariN VenkateswaramurthyAli Alqahtani
- Topics
- Peroxisome Proliferator-Activated Receptors (8 papers)Eicosanoids and Hypertension Pharmacology (5 papers)Medicinal Plants and Neuroprotection (3 papers)
- Cited by
- PharmacologyNephrologyForestry
- Journals
- British Journal of PharmacologyEuropean Journal of PharmacologyJournal of Solid State Chemistry
- Partner nations
- IndiaSaudi ArabiaUnited Kingdom
In The Last Decade
Nanjaian Mahadevan
35 papers receiving 751 citations
Peers
Comparison fields: 5 of 103
- Molecular Biology 230
- Pharmacology 169
- Plant Science 125
- Cardiology and Cardiovascular Medicine 113
- Endocrinology, Diabetes and Metabolism 105
Countries citing papers authored by Nanjaian Mahadevan
This map shows the geographic impact of Nanjaian Mahadevan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanjaian Mahadevan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanjaian Mahadevan more than expected).
Fields of papers citing papers by Nanjaian Mahadevan
This network shows the impact of papers produced by Nanjaian Mahadevan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanjaian Mahadevan. The network helps show where Nanjaian Mahadevan may publish in the future.
Co-authorship network of co-authors of Nanjaian Mahadevan
This figure shows the co-authorship network connecting the top 25 collaborators of Nanjaian Mahadevan. A scholar is included among the top collaborators of Nanjaian Mahadevan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanjaian Mahadevan. Nanjaian Mahadevan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 41 | |
| 2 | 22 | |
| 3 | 41 | |
| 4 | 3 | |
| 5 | 13 | |
| 6 | 25 | |
| 7 | 30 | |
| 8 | 9 | |
| 9 | 20 | |
| 10 | 48 | |
| 11 | 32 | |
| 12 | 14 | |
| 13 | 10 | |
| 14 | 50 | |
| 15 | 78 | |
| 16 | Antihyperlipidemic effect of hydroalcoholic extract of Kenaf(Hibiscus cannabinus L.) leaves in high fat diet fed rats | 17 |
| 17 | Anticonvulsants from nature. | 9 |
| 18 | 25 | |
| 19 | Development Of Mono Ingredient Herbal Neuroleptic Tablet For Better Psychiatric Therapy | 1 |
| 20 | 22 |
About Nanjaian Mahadevan
Nanjaian Mahadevan is a scholar working on Biochemistry, Nephrology and Applied Microbiology and Biotechnology, having authored 37 papers that have together received 814 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (8 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Medicinal Plants and Neuroprotection (3 papers). The work is most often cited by research in Pharmacology (169 citations), Nephrology (92 citations) and Forestry (32 citations). Nanjaian Mahadevan has collaborated with scholars based in India, Saudi Arabia and United Kingdom. Frequent co-authors include Pitchai Balakumar, Gaurav Taneja, S. Ramanathan, Sanjeev Kalra, Abdullatif Bin Muhsinah, Abdulrhman Alsayari, N Venkateswaramurthy, Ali Alqahtani, Noohu Abdulla Khan and Nidhi Sharma. Their work appears in journals such as British Journal of Pharmacology, European Journal of Pharmacology and Journal of Solid State Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.